These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 23795522)
1. Economic lessons in the land of plenty. Pontious JM J Okla State Med Assoc; 2013 Apr; 106(4):123-4. PubMed ID: 23795522 [No Abstract] [Full Text] [Related]
2. Clinical trials and health economics--a marriage of convenience or a marriage made in heaven? Bakhai A; Greenberg D J Med Econ; 2008; 11(3):541-6. PubMed ID: 19450103 [No Abstract] [Full Text] [Related]
3. [Factors in expenditures for pharmaceuticals]. PEQUIGNOT H; ROSCH G; VESSEREAU A Sem Med Prof Med Soc; 1959 Aug; 35():783-4. PubMed ID: 14431691 [No Abstract] [Full Text] [Related]
4. [Material economics--an important field in health affairs]. Michael R; Albold H; Gec H Pharm Prax; 1969; 6():121-5. PubMed ID: 5808995 [No Abstract] [Full Text] [Related]
5. The concept of essential medicines: lessons for rich countries. Hogerzeil HV BMJ; 2004 Nov; 329(7475):1169-72. PubMed ID: 15539676 [TBL] [Abstract][Full Text] [Related]
6. Price and value: the pharmacoeconomics of scarcity. Lyles A Clin Ther; 2012 Feb; 34(2):432-3. PubMed ID: 22325734 [No Abstract] [Full Text] [Related]
7. [The practising physician and prescription of medicines]. Bentzen AJ Ugeskr Laeger; 1967 Nov; 129(48):1622-4. PubMed ID: 5587489 [No Abstract] [Full Text] [Related]
8. Economic and policy implications of reimportation: a Canadian perspective. Ward C Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165 [No Abstract] [Full Text] [Related]
9. Greeks feel effects of drug shortages caused by austerity measures. Sukkar E BMJ; 2012 May; 344():e3589. PubMed ID: 22614060 [No Abstract] [Full Text] [Related]
10. [System of organization, planning and conduction of cooperative relations in Health Department in the 2nd stage of the new economic system]. Bertling D; Danowski K Pharm Prax; 1967; 12():338-40. PubMed ID: 5616582 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396 [No Abstract] [Full Text] [Related]
12. Pharmaceuticals and medical devices: business practices. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448 [No Abstract] [Full Text] [Related]
13. [Contributions on pharmaceutical economics. 14. On the scientific systematic and theoretical work of the study group Organization and Economics of Drug Supply]. Seidlein HJ Pharm Prax; 1968; 8():182-8. PubMed ID: 5711291 [No Abstract] [Full Text] [Related]
14. The emerging specialty pharmaceutical market segment. Giaquinta D Manag Care Interface; 2003 Apr; 16(4):35-6. PubMed ID: 12747139 [No Abstract] [Full Text] [Related]
15. The road to recovery. Morel CM; Carvalheiro JR; Romero CN; Costa EA; Buss PM Nature; 2007 Sep; 449(7159):180-2. PubMed ID: 17851516 [No Abstract] [Full Text] [Related]
16. Where does drug importation stand now? Guglielmo WJ Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085 [No Abstract] [Full Text] [Related]
18. Providers fuel 'gray market'. Some sell while others buy during drug shortage. Lee J Mod Healthc; 2011 Sep; 41(36):8-9. PubMed ID: 21928533 [No Abstract] [Full Text] [Related]
19. Biotech products pose distribution challenges. Szeinbach SL; Gillenwater EL Am Pharm; 1994 Mar; NS34(3):19-20. PubMed ID: 8192094 [No Abstract] [Full Text] [Related]
20. Adapting pharmacoeconomic data and methods to extend the postpublication utility of analyses. Lyles A Clin Ther; 2009 Jan; 31(1):192-3. PubMed ID: 19243717 [No Abstract] [Full Text] [Related] [Next] [New Search]